MUC13 and colitis: Using a Muc13 knockout mouse (Muc13-/-) and a colitis-associated colorectal (CAC) tumorigenesis model induced by AOM and followed by DDS, Sheng et al. showed that Muc13-/- mice had fewer and smaller tumors and decreased hyperplasia compared to wild-type CAC models [105].